<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02601911</url>
  </required_header>
  <id_info>
    <org_study_id>AzadUMS P/66/D</org_study_id>
    <nct_id>NCT02601911</nct_id>
  </id_info>
  <brief_title>Effect of Premedication on Success of Inferior Alveolar Nerve Block Injection</brief_title>
  <official_title>Comparison of Ketorolac and Ketorolac/Acetaminophen on Success of Inferior Alveolar Nerve Block Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azad University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azad University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is effect of premedication on success of inferior alveolar nerve block
      injection. Sixty healthy adult volunteers including criteria, are participating. The patients
      will be divided into 3 groups and will be randomly given one of premedications including 1)
      10 mg Ketorolac, 2) 10 mg Ketorolac plus 1000mg Acetaminophen, and 3)Placebo, 45 minutes
      before applying the injection. All patients will receive standard Inferior Alveolar Nerve
      Block injection . Patients with no lip numbness and positive responses to cold and electric
      pulp tests would be excluded from the study. Endodontic access preparation will be initiated
      15 minutes after Inferior Alveolar Nerve Block injection. Pain during treatment will be
      recorded using a Heft parker Visual Analog Scale(VAS). Success will be considered as no or
      mild pain (VAS≤54) during caries/dentin removal, access cavity preparation and working
      lengths measurements. Data will be analysed using Mann-U-Whitney and Kruskal-wallis tests.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is effect of premedication on success of inferior alveolar nerve block
      injection. Sixty healthy adult volunteers with including criteria and with no spontaneous
      pain, reporting no or mild (Visual analog scale≤54) pain in response to cold testing and
      electric pulp tester, are participating. The patients will be divided into 3 groups on a
      random basis and will be randomly given one of the oral medications including 1) 10 mg
      Ketorolac, 2) 10 mg Ketorolac plus 1000mg Acetaminophen, and 3)Placebo, 45 minutes before
      applying the injection. All patients will receive standard Inferior Alveolar Nerve Block
      injection with one carpule of 4% Articaine with 1:100000 Epinephrine. Patients with no
      anesthetic sign (lip numbness) and positive responses to cold and electric pulp tests would
      be excluded from the study. Endodontic access preparation will be initiated 15 minutes after
      Inferior Alveolar Nerve Block injection. Pain during treatment will be recorded using a Heft
      parker Visual Analog Scale(VAS). Success will be considered as no or mild pain (VAS≤54)
      during caries/dentin removal, access cavity preparation and working lengths measurements.
      Data will be analysed using Mann-U-Whitney and Kruskal-wallis tests.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain rate using Visual Analog Scale (VAS) form</measure>
    <time_frame>45 minutes</time_frame>
    <description>Pain during caries and dentin removal , access cavity preparation and working lengths measurements using VAS form.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Irreversible Pulpitis</condition>
  <arm_group>
    <arm_group_label>Ketorolac tromethanine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive a caplet including10 mg Ketorolac tromethamine 45 minutes before applying infra alveolar nerve block injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group receive a caplet including10 mg Ketorolac tromethamine/ 1000 mg Acetaminophen, before applying the injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This group receive a caplet including placebo, before applying the injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac Tromethamine</intervention_name>
    <description>10 mg Ketorolac tromethamine is applied 45 minutes before the injection.</description>
    <arm_group_label>Ketorolac tromethanine</arm_group_label>
    <other_name>Toradol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>10 mg Ketorolac tromethamine/ 1000mg Acetaminophen application before injection.</description>
    <arm_group_label>Acetaminophen</arm_group_label>
    <other_name>non</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>This group receive the caplet including placebo 45 minutes before the injection.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with age ranged 18-65

          -  without systemic diseases

          -  without any medicine consumption

          -  non smoking

          -  non pregnant

          -  non breast feeding

          -  with asymptomatic irreversible pulpitis ( Visual Analog Scale ≤ 54) in one mandibular
             molar that needs root canal treatment

          -  without any medicine consumption or analgesic and sedation

          -  understand and sign the VAS and consent forms

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nahid Mohammadzadeh Akhlaghi, DDS, MDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dental Branch, AZad UMS</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2015</study_first_submitted>
  <study_first_submitted_qc>November 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2015</study_first_posted>
  <last_update_submitted>September 17, 2016</last_update_submitted>
  <last_update_submitted_qc>September 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azad University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Nahid Mohammadzadeh Akhlaghi</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Failure</keyword>
  <keyword>Injection</keyword>
  <keyword>Ketorolac</keyword>
  <keyword>Premedication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

